Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate

NCT04598620 is registered in ClinicalTrials.gov with Inger Lise Gade as lead sponsor.

NCT NCT04598620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04598620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate
Lead sponsor
Inger Lise Gade
Phase
Observational
Overall status
Completed
Start date
September 19, 2020
Completion date
October 1, 2021
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid19